Inhibition of matrix metalloproteinases and inducible nitric oxide synthase by andrographolide in human osteoarthritic chondrocytes

References

• Goldring MB, Goldring SR. Osteoarthritis. J Cell Physiol. 2007; 213:626–634.
   PubMed Web of Science ®Google Scholar
• Lee R, Kean WF. Obesity and knee osteoarthritis. Inflammopharmacology. 2012.
   Google Scholar
• Loeser RF. Aging and osteoarthritis. Curr Opin Rheumatol. 2011; 23:492–496.
   PubMed Web of Science ®Google Scholar
• Goldring MB, Marcu KB. Cartilage homeostasis in health and rheumatic diseases. Arthr Res Ther 2009;11.
   Google Scholar
• Chevalier X, Conrozier T, Richette P. Desperately looking for the right target in osteoarthritis: the anti-IL-1 strategy. Arthr Res Ther. 2011; 13:124
   PubMed Web of Science ®Google Scholar
• Dahlberg L, Billinghurst RC, Manner P, Nelson F, Webb G, Ionescu M, et al. Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1). Arthr Rheum. 2000; 43:673–682.
   PubMed Web of Science ®Google Scholar
• Smith GN Jr. The role of collagenolytic matrix metalloproteinases in the loss of articular cartilage in osteoarthritis. Front Biosci. 2006; 11:3081–3095.
   PubMedGoogle Scholar
• Poole AR. Biochemical/immunochemical biomarkers of osteoarthritis: utility for prediction of incident or progressive osteoarthritis. Rheum Dis Clin North Am. 2003; 29:803–818.
   PubMed Web of Science ®Google Scholar
• Abramson SB. Nitric oxide in inflammation and pain associated with osteoarthritis. Arthr Res Ther. 2008; 10Suppl 2S2
   PubMedGoogle Scholar
• Nathan C. Inducible nitric oxide synthase: what difference does it make?. J Clin Invest. 1997; 100:2417–2423.
   PubMed Web of Science ®Google Scholar
• Amin AR, Abramson SB. The role of nitric oxide in articular cartilage breakdown in osteoarthritis. Curr Opin Rheumatol. 1998; 10:263–268.
   PubMedGoogle Scholar
• Xie QW, Kashiwabara Y, Nathan C. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J Biol Chem. 1994; 269:4705–4708.
   PubMed Web of Science ®Google Scholar
• Marcu KB, Otero M, Olivotto E, Borzi RM, Goldring MB. NF-kappaB signaling: multiple angles to target OA. Curr Drug Targets. 2010; 11:599–613.
   PubMed Web of Science ®Google Scholar
• Dai GF, Zhao J, Jiang ZW, Zhu LP, Xu HW, Ma WY, et al. Anti-inflammatory effect of novel andrographolide derivatives through inhibition of NO and PGE(2) production. Int Immunopharmacol 2011; 11(12):2144–2149.
   Google Scholar
• Jiang X, Yu P, Jiang J, Zhang Z, Wang Z, Yang Z, et al. Synthesis and evaluation of antibacterial activities of andrographolide analogues. Eur J Med Chem. 2009; 44:2936–2943.
   PubMedGoogle Scholar
• Lee YC, Lin HH, Hsu CH, Wang CJ, Chiang TA, Chen JH. Inhibitory effects of andrographolide on migration and invasion in human non-small cell lung cancer A549 cells via down-regulation of PI3 K/Akt signaling pathway. Eur J Pharmacol. 2010; 632:23–32.
   PubMed Web of Science ®Google Scholar
• Shi MD, Lin HH, Chiang TA, Tsai LY, Tsai SM, Lee YC, et al. Andrographolide could inhibit human colorectal carcinoma Lovo cells migration and invasion via down-regulation of MMP-7 expression. Chem Biol Interact. 2009; 180:344–352.
   Google Scholar
• Burgos RA, Hancke JL, Bertoglio JC, Aguirre V, Arriagada S, Calvo M, et al. Efficacy of an Andrographis paniculata composition for the relief of rheumatoid arthritis symptoms: a prospective randomized placebo-controlled trial. Clin Rheumatol. 2009; 28:931–946.
   PubMed Web of Science ®Google Scholar
• Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthr Rheum. 1986; 29:1039–1049.
   PubMed Web of Science ®Google Scholar
• Altman R, Alarcon G, Appelrouth D, Bloch D, Borenstein D, Brandt K, et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthr Rheum. 1991; 34:505–514.
   PubMed Web of Science ®Google Scholar
• Lieberthal W, Triaca V, Koh JS, Pagano PJ, Levine JS. Role of superoxide in apoptosis induced by growth factor withdrawal. Am J Physiol. 1998; 275:F691–F702.
   Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001; 25:402–408.
   PubMed Web of Science ®Google Scholar
• Palmieri B, Lodi D, Capone S. Osteoarthritis and degenerative joint disease: local treatment options update. Acta Biomed. 2010; 81:94–100.
   PubMedGoogle Scholar
• Malemud CJ. Anticytokine therapy for osteoarthritis: evidence to date. Drugs Aging. 2010; 27:95–115.
   PubMed Web of Science ®Google Scholar
• Aigner T, Sachse A, Gebhard PM, Roach HI. Osteoarthritis: pathobiology-targets and ways for therapeutic intervention. Adv Drug Deliv Rev. 2006; 58:128–149.
   PubMed Web of Science ®Google Scholar
• Nagase H, Woessner JF Jr. Matrix metalloproteinases. J Biol Chem. 1999; 274:21491–21494.
   PubMed Web of Science ®Google Scholar
• Brinckerhoff CE, Matrisian LM. Matrix metalloproteinases: a tail of a frog that became a prince. Nat Rev Mol Cell Biol. 2002; 3:207–214.
   PubMed Web of Science ®Google Scholar
• Murphy G, Knauper V, Atkinson S, Butler G, English W, Hutton M, et al. Matrix metalloproteinases in arthritic disease. Arthr Res. 2002; 4Suppl 3S39–S49.
   PubMedGoogle Scholar
• Takaishi H, Kimura T, Dalal S, Okada Y, D’Armiento J. Joint diseases and matrix metalloproteinases: a role for MMP-13. Curr Pharm Biotechnol. 2008; 9:47–54.
   PubMed Web of Science ®Google Scholar
• Pratheeshkumar P, Kuttan G. Andrographolide inhibits human umbilical vein endothelial cell invasion and migration by regulating MMP-2 and MMP-9 during angiogenesis. J Environ Pathol Toxicol Oncol. 2011; 30:33–41.
   PubMed Web of Science ®Google Scholar
• Lee KC, Chang HH, Chung YH, Lee TY. Andrographolide acts as an anti-inflammatory agent in LPS-stimulated RAW264.7 macrophages by inhibiting STAT3-mediated suppression of the NF-kappaB pathway. J Ethnopharmacol. 2011; 135:678–684.
   PubMed Web of Science ®Google Scholar
• Henrotin YE, Bruckner P, Pujol JP. The role of reactive oxygen species in homeostasis and degradation of cartilage. Osteoarthr Cartil. 2003; 11:747–755.
   PubMed Web of Science ®Google Scholar
• Pelletier JP, Jovanovic D, Fernandes JC, Manning P, Connor JR, Currie MG, et al. Reduced progression of experimental osteoarthritis in vivo by selective inhibition of inducible nitric oxide synthase. Arthr Rheum. 1998; 41:1275–1286.
   PubMed Web of Science ®Google Scholar
• Nagase H, Kashiwagi M. Aggrecanases and cartilage matrix degradation. Arthr Res Ther. 2003; 5:94–103.
   PubMed Web of Science ®Google Scholar
• Malfait AM, Liu RQ, Ijiri K, Komiya S, Tortorella MD. Inhibition of ADAM-TS4 and ADAM-TS5 prevents aggrecan degradation in osteoarthritic cartilage. J Biol Chem. 2002; 277:22201–22208.
   PubMed Web of Science ®Google Scholar
• Vincenti MP, Brinckerhoff CE. Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: integration of complex signaling pathways for the recruitment of gene-specific transcription factors. Arthr Res. 2002; 4:157–164.
   PubMedGoogle Scholar
• Tian B, Brasier AR. Identification of a nuclear factor kappa B-dependent gene network. Recent Prog Horm Res. 2003; 58:95–130.
   PubMedGoogle Scholar
• Hayden MS, Ghosh S. Signaling to NF-kappaB. Genes Dev. 2004; 18:2195–2224.
   PubMed Web of Science ®Google Scholar
• Lee WR, Chung CL, Hsiao CJ, Chou YC, Hsueh PJ, Yang PC, et al. Suppression of matrix metalloproteinase-9 expression by andrographolide in human monocytic THP-1 cells via inhibition of NF-kappaB activation. Phytomedicine 2012.
   Google Scholar